DERICIP

Description

DERICIP is a prescription bronchodilator from Cipla Ltd. containing Etofylline + Theophylline. It relaxes airway muscles and widens the bronchi, helping air move in and out more easily—thereby easing wheezing, chest tightness, cough, and shortness of breath in COPD and asthma.

Available strengths on 1mg

• Dericip 77mg/23mg Tablet (Etofylline 77 mg + Theophylline 23 mg)

• Dericip 231mg/69mg Tablet (Etofylline 231 mg + Theophylline 69 mg)

• Dericip Retard 300 Tablet PR (sustained release; 231 mg + 69 mg)
  All are listed with Cipla as the marketer.

How it works
The two bronchodilators relax airway smooth muscle and widen the air passages; they also help reduce mucus build-up—so breathing becomes easier and symptoms reduce. 1mg

How to take (per 1mg guidance)
Swallow whole as advised by the doctor. Take on an empty stomach and avoid caffeine/chocolate (e.g., tea, coffee, cocoa) which can interact with methylxanthines. Do not crush/chew.

Common side effects
Nausea, vomiting, headache, restlessness, dry mouth, dizziness, stomach upset. Most are temporary; contact a doctor if persistent.

Safety advice (as shown on 1mg)

• Alcohol: unsafe with Dericip.

• Pregnancy/Breastfeeding: consult your doctor; may be unsafe—provider will weigh risks/benefits.

• Liver issues: use with caution; dose adjustment may be needed.